Journal Mobile Options
Table of Contents
Vol. 224, No. 3, 2012
Issue release date: July 2012
Free Access
Dermatology 2012;224:209–211
(DOI:10.1159/000336775)

Labial Melanotic Macule: A Potential Pitfall on Reflectance Confocal Microscopy

Erfan N.a · Hofman V.b · Desruelles F.a · Passeron T.a · Ortonne J.P.a · Lacour J.P.a · Bahadoran P.a, c
Departments of aDermatology, bPathology and cINSERM U895 Team, 9 Pasteur Hospital, University of Sophia-Antipolis, Nice, France
email Corresponding Author


 Outline


 goto top of outline Key Words

  • Labial melanotic macule
  • Reflectance confocal microscopy
  • Melanoma

 goto top of outline Abstract

No abstract available

Copyright © 2010 S. Karger AG, Basel


goto top of outline  

goto top of outline Introduction

Labial melanotic macules (LMM) are benign pigmented lesions that can be difficult to differentiate from melanoma on the mucous membrane and the mucocutaneous junction [1,2]. LMM are secondary to a variable increase in melanin in the basal layer leading to hyperpigmentation of the basal keratinocytes along with an increase in the number of melanophages, and a normal or slightly increased number of melanocytes [2].

Reflectance confocal microscopy (RCM) is a novel non-invasive imaging technique that has gained substantial recognition because of its diagnostic uses in many skin pathologies.

Here we report the RCM findings in 4 cases of LMM and discuss the significance of these findings with regard to RCM criteria of other pigmented lesions.

goto top of outline Case Reports

Case 1. A 55-year-old woman presented with a history of a pigmented macule of the lower lip. The lesion appeared insidiously over a period of 6 months at the left lateral aspect of the lower lip. Clinical examination showed a brown-grey macule, measuring 5 mm (fig. 1a). Dermoscopy showed an ill-defined heterogeneously pigmented lesion (fig. 1b). RCM showed a normal epidermis with a honeycomb pattern and absence of atypical cells, and at the dermo-epidermal junction (DEJ) bright refractile cells surrounding the dermal papillae (fig. 1c). Notably, a significant proportion of these cells were melanocytes of variable size and shape and markedly branching dendrites. The lesion was biopsied, and histopathological evaluation showed a lentiginous background with hyperpigmented keratinocytes (fig. 1d). There was evidence of dermal elastosis and absence of cytonuclear atypia with regard to melanocytes. Immunostaining with melan-A antibody confirmed a moderate augmentation in the number of basal melanocytes with branching dendrites extending into the suprabasal layers of the epidermis, sometimes resembling the spreading branches of a tree (fig. 1e).

FIG01
Fig. 1.a Clinical image of the patient’s lower lip showing a grey-brown heterogeneous macule. b Dermoscopic image demonstrating non-specific amorphous pigmentation. c RCM image showing increased dermal papillae surrounded by large, atypical dendritic cells. d Histopathological image showing a lentiginous background with multiple hyperpigmented keratinocytes. ×100. e Melan-A immunostaining showing an increase in highly dendritic melanocytes at the basal layer. ×400.

Case 2. A 60-year-old man presented with a long-standing history of a pigmented macule of the lower lip. Clinical examination showed a brown homogeneous macule measuring 3 mm (fig. 2a). Dermoscopy showed a network pattern (fig. 2b). RCM showed a normal epidermis and numerous atypical dendritic cells at the DEJ (fig. 2c). Taking into consideration the benign clinical and dermoscopic presentations of the lesion, no biopsy was performed.

FIG02
Fig. 2.a Clinical image of the patient’s lower lip showing a small, discrete, homogeneously pigmented macule. b Dermoscopic image of the lesion showing a brown uniformly pigmented macule with a reticular pattern. c RCM image showing multiple atypical dendritic cells around the dermal papilla.

Case 3. A 26-year-old woman presented with a pigmented macule of the lower lip that had appeared 2 years before. The lesion was homogeneous, brown/black, measuring 4 × 3 mm (fig. 3a). Dermoscopy showed a benign so-called hyphal pattern (fig. 3b) [1]. RCM showed a normal epidermis and dendritic cells at the DEJ (fig. 3c). The lesion remained unchanged during consecutive digital monitoring.

FIG03
Fig. 3.a Clinical image of a pigmented macule of the lower lip showing a homogeneous, brown/black aspect and measuring 4 × 3 mm. b Dermoscopy showing a benign ‘hyphal’ pattern. c RCM showing a normal epidermis and dendritic cells at the DEJ (arrows).

Case 4. A 37-year-old woman was referred for dermatological surveillance of her naevi. The patient was found to have 2 pigmented macules of the lower lip that had appeared 1 year prior to presentation (fig. 4a). Clinical examination and dermoscopy (fig. 4b) were not suspicious. RCM showed some dendritic cells at the DEJ (fig. 4c). The lesion remained unchanged during consecutive digital monitoring.

FIG04
Fig. 4.a Clinical image showing two homogeneously pigmented macules of the lower lip. b Dermoscopy showing slightly pigmented macules with a reticular pattern. c RCM showing some dendritic cells at the DEJ (arrows).

goto top of outline Comments

LMM are commonly seen in daily practice and may be difficult to differentiate from mucosal malignant melanoma. RCM, a novel non-invasive imaging technique, is now widely recognized as a reliable tool to discriminate between benign and malignant melanocytic proliferations of the skin.

Noteworthy, in our 4 cases of LMM, the more conspicuous RCM sign was the presence of abundant and highly dendritic cells at the DEJ which were confirmed to be normal melanocytes on histology. These findings are in accordance with previous histopathological studies of LMM which portrayed an increase in dendritic melanocytes in these lesions, confined to the basal layer, and without nest formation [2,3,4].

In actinic lentigines, the most common type of benign pigmented macules of the skin, dendritic cells, are not detectable by RCM [5], possibly because in these lesions the majority of melanocytes present in the basal layer of the epidermis are suspended in the dermis and are called ‘pendulum melanocytes’ [6]. On the other hand, the presence of dendritic melanocytes on RCM is considered to be an important diagnosis criterion of lentigo maligna [5].

In conclusion, LMM should not be confounded for a malignant lesion due to the presence on RCM of atypical dendritic cells within the epidermis. RCM criteria for lentigo maligna [5], when applied to such lesions, could lead to false positivity if these differences between skin and mucosa are overlooked. Additional studies are needed to allow the definition of specific RCM criteria for mucosal pigmented lesions.

goto top of outline Disclosure Statement

The authors have no conflict of interest to disclose.


 goto top of outline References
  1. Lin J, Koga H, Takata M, et al: Dermoscopy of pigmented lesions on mucocutaneous junction and mucous membrane. Br J Dermatol 2009;161:1255–1261.
  2. Ho KK, Dervan P, et al: Labial melanotic macule: a clinical histopathologic and ultrastructural study. J Am Acad Dermatol 1993;28:33–39.
  3. Sexton FM, Maize JC: Melanotic macules and melanoacanthomas of the lip. A comparative study with census of the basal melanocyte population. Am J Dermatopathol 1987;9:438–444.
  4. Moore RT, Chae KA, Rhodes AR: Laugier and Hunziker pigmentation: a lentiginous proliferation of melanocytes. J Am Acad Dermatol 2004;50(suppl):S70–S74.

    External Resources

  5. Noblesse E, Nizard C, Cario-André M, et al: Skin ultrastructure in senile lentigo. Skin Pharmacol Physiol 2006;19:95–100.
  6. Langley RG, Burton E, Walsh N, et al: In vivo confocal scanning laser microscopy of benign lentigines: comparison to conventional histology and in vivo characteristics of lentigo maligna. J Am Acad Dermatol 2006;55:88–97.

 goto top of outline Author Contacts

Philippe Bahadoran, MD
CHU Nice, Hôpital Archet-2
151, route Saint-Antoine-Ginestière
FR–06202 Nice (France)
Tel. +33 492 036 223, E-Mail bahadoran.p@chu-nice.fr


 goto top of outline Article Information

Published online: March 9, 2012
Number of Print Pages : 3
Number of Figures : 4, Number of Tables : 0, Number of References : 6


 goto top of outline Publication Details

Dermatology

Vol. 224, No. 3, Year 2012 (Cover Date: July 2012)

Journal Editor: Saurat J.-H. (Geneva)
ISSN: 1018-8665 (Print), eISSN: 1421-9832 (Online)

For additional information: http://www.karger.com/DRM


Copyright / Drug Dosage / Disclaimer

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

First-Page Preview
Abstract of Letter to Dermatology

 goto top of outline Author Contacts

Philippe Bahadoran, MD
CHU Nice, Hôpital Archet-2
151, route Saint-Antoine-Ginestière
FR–06202 Nice (France)
Tel. +33 492 036 223, E-Mail bahadoran.p@chu-nice.fr


 goto top of outline Article Information

Published online: March 9, 2012
Number of Print Pages : 3
Number of Figures : 4, Number of Tables : 0, Number of References : 6


 goto top of outline Publication Details

Dermatology

Vol. 224, No. 3, Year 2012 (Cover Date: July 2012)

Journal Editor: Saurat J.-H. (Geneva)
ISSN: 1018-8665 (Print), eISSN: 1421-9832 (Online)

For additional information: http://www.karger.com/DRM


Copyright / Drug Dosage

Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher or, in the case of photocopying, direct payment of a specified fee to the Copyright Clearance Center.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in goverment regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.

References

  1. Lin J, Koga H, Takata M, et al: Dermoscopy of pigmented lesions on mucocutaneous junction and mucous membrane. Br J Dermatol 2009;161:1255–1261.
  2. Ho KK, Dervan P, et al: Labial melanotic macule: a clinical histopathologic and ultrastructural study. J Am Acad Dermatol 1993;28:33–39.
  3. Sexton FM, Maize JC: Melanotic macules and melanoacanthomas of the lip. A comparative study with census of the basal melanocyte population. Am J Dermatopathol 1987;9:438–444.
  4. Moore RT, Chae KA, Rhodes AR: Laugier and Hunziker pigmentation: a lentiginous proliferation of melanocytes. J Am Acad Dermatol 2004;50(suppl):S70–S74.

    External Resources

  5. Noblesse E, Nizard C, Cario-André M, et al: Skin ultrastructure in senile lentigo. Skin Pharmacol Physiol 2006;19:95–100.
  6. Langley RG, Burton E, Walsh N, et al: In vivo confocal scanning laser microscopy of benign lentigines: comparison to conventional histology and in vivo characteristics of lentigo maligna. J Am Acad Dermatol 2006;55:88–97.